Check the time stamp on this data. Updated AI-Generated Signals for Repligen Corporation (RGEN) available here: RGEN. Type a ...
What Happened: Grygiel's recent move involves selling 1,589 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total ...
Quantum computing might be Wall Street's next big hype cycle. Rigetti offers excellent exposure to the infrastructure side of the opportunity. But is it too early to get involved? Investors will want ...
Repligen Corporation’s stock is up 15.5% in 2025, up 0.2% in the previous five trading days and down 14.1% in the past year.
RGEN currently has a PEG ratio of 4.76. Another notable valuation metric for HRMY is its P/B ratio of 3.71. The P/B is a method of comparing a stock's market value to its book value, which is defined ...
Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...
Repligen (RGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...
According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $184.73. RGEN stock opened at $165.89 on Friday. The firm has a market ...
With analyst price targets ranging from $160 ... You can also see if RGEN appears on our undervalued or overvalued stock lists. These tools provide a clearer picture of investment opportunities ...
H.C. Wainwright lowered the firm’s price target on Repligen (RGEN) to $180 from $240 and keeps a Buy rating on the shares. The firm says the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results